ProfileGDS5822 / ILMN_2772632
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 99% 74% 99% 99% 91% 97% 94% 98% 99% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15801.799
GSM1276600PDAC Late Ablation Control 281.774
GSM1276601PDAC Late Ablation Control 34291.599
GSM1276602PDAC Late Ablation 14614.499
GSM1276603PDAC Late Ablation 2602.491
GSM1276604PDAC Late Ablation 32719.797
GSM1303940PDAC Late Ablation_anti-CTLA4 11059.394
GSM1303941PDAC Late Ablation_anti-CTLA4 23255.598
GSM1303942PDAC Late Ablation_anti-CTLA4 35356.999